Drug Report History #274457
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v3-EN | Version v2-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2026-01-02 (Updated) | 2025-12-16 |
| Drug Identification Number | 02505517 | 02505517 |
| Brand name | BIVALIRUDIN INJECTION | BIVALIRUDIN INJECTION |
| Common or Proper name | Bivalirudin Injectable 250mg/50mL 10vials | Bivalirudin Injectable 250mg/50mL 10vials |
| Company Name | AVIR PHARMA INC. | AVIR PHARMA INC. |
| Ingredients | BIVALIRUDIN | BIVALIRUDIN |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 250mg /50ml 10 vials | 250mg /50ml 10 vials |
| Anatomical Therapeutical Chemical (ATC) code | B01AE | B01AE |
| Anatomical Therapeutical Chemical (ATC) description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2026-01-01 | 2026-01-01 |
| Actual start date | ||
| Estimated end date | 2026-06-30 | 2026-06-30 |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Product under allocation | Product under allocation |
| Health Canada comments |